vs
CarParts.com, Inc.（PRTS）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是CarParts.com, Inc.的1.1倍（$127.1M vs $120.4M），再鼎医药同比增速更快（17.1% vs -9.8%），过去两年再鼎医药的营收复合增速更高（20.8% vs -8.6%）
GPC是一家总部位于美国佐治亚州亚特兰大的汽车与工业零部件分销商，1928年由弗雷泽兄弟创立，目前拥有约六万名员工。除美国本土市场外，公司业务还覆盖澳大拉西亚、比利时、加拿大、法国、德国、墨西哥、荷兰、波兰及英国，旗下拥有知名汽车零部件零售商NAPA Auto Parts和工业零部件分销商Motion。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PRTS vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$120.4M
营收增速更快
ZLAB
高出26.9%
-9.8%
两年增速更快
ZLAB
近两年复合增速
-8.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.4M | $127.1M |
| 净利润 | $-11.6M | — |
| 毛利率 | 33.2% | 51.0% |
| 营业利润率 | — | -54.6% |
| 净利率 | -9.6% | — |
| 营收同比 | -9.8% | 17.1% |
| 净利润同比 | 25.0% | — |
| 每股收益（稀释后） | $-0.82 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRTSZLAB
| Q4 25 | $120.4M | $127.1M | ||
| Q3 25 | $127.8M | $115.4M | ||
| Q2 25 | $151.9M | $109.1M | ||
| Q1 25 | $147.4M | $105.7M | ||
| Q4 24 | $133.5M | $108.5M | ||
| Q3 24 | $144.8M | $101.8M | ||
| Q2 24 | $144.3M | $100.1M | ||
| Q1 24 | — | $87.1M |
净利润PRTSZLAB
| Q4 25 | $-11.6M | — | ||
| Q3 25 | $-10.9M | $-36.0M | ||
| Q2 25 | $-12.7M | $-40.7M | ||
| Q1 25 | $-15.3M | $-48.4M | ||
| Q4 24 | $-15.4M | — | ||
| Q3 24 | $-10.0M | $-41.7M | ||
| Q2 24 | $-8.7M | $-80.3M | ||
| Q1 24 | — | $-53.5M |
毛利率PRTSZLAB
| Q4 25 | 33.2% | 51.0% | ||
| Q3 25 | 33.1% | 59.5% | ||
| Q2 25 | 32.8% | 60.6% | ||
| Q1 25 | 32.1% | 63.6% | ||
| Q4 24 | 32.5% | 61.5% | ||
| Q3 24 | 35.2% | 64.1% | ||
| Q2 24 | 33.5% | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率PRTSZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | -7.9% | -42.3% | ||
| Q2 25 | -8.2% | -50.3% | ||
| Q1 25 | -10.3% | -53.3% | ||
| Q4 24 | -11.6% | -62.6% | ||
| Q3 24 | -6.9% | -66.6% | ||
| Q2 24 | -6.0% | -76.0% | ||
| Q1 24 | — | -80.7% |
净利率PRTSZLAB
| Q4 25 | -9.6% | — | ||
| Q3 25 | -8.5% | -31.2% | ||
| Q2 25 | -8.4% | -37.3% | ||
| Q1 25 | -10.4% | -45.8% | ||
| Q4 24 | -11.5% | — | ||
| Q3 24 | -6.9% | -40.9% | ||
| Q2 24 | -6.0% | -80.2% | ||
| Q1 24 | — | -61.4% |
每股收益（稀释后）PRTSZLAB
| Q4 25 | $-0.82 | $-0.05 | ||
| Q3 25 | $-0.19 | $-0.03 | ||
| Q2 25 | $-0.23 | $-0.04 | ||
| Q1 25 | $-0.27 | $-0.04 | ||
| Q4 24 | $-0.28 | $-0.09 | ||
| Q3 24 | $-0.17 | $-0.04 | ||
| Q2 24 | $-0.15 | $-0.08 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.8M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $715.5M |
| 总资产 | $184.9M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRTSZLAB
| Q4 25 | $25.8M | $689.6M | ||
| Q3 25 | — | $717.2M | ||
| Q2 25 | — | $732.2M | ||
| Q1 25 | — | $757.3M | ||
| Q4 24 | — | $779.7M | ||
| Q3 24 | — | $616.1M | ||
| Q2 24 | — | $630.0M | ||
| Q1 24 | — | $650.8M |
股东权益PRTSZLAB
| Q4 25 | $53.5M | $715.5M | ||
| Q3 25 | $64.2M | $759.9M | ||
| Q2 25 | $62.4M | $791.7M | ||
| Q1 25 | $72.8M | $810.8M | ||
| Q4 24 | $85.2M | $840.9M | ||
| Q3 24 | $97.2M | $667.7M | ||
| Q2 24 | $103.9M | $704.2M | ||
| Q1 24 | — | $762.2M |
总资产PRTSZLAB
| Q4 25 | $184.9M | $1.2B | ||
| Q3 25 | $200.3M | $1.2B | ||
| Q2 25 | $189.6M | $1.2B | ||
| Q1 25 | $216.5M | $1.2B | ||
| Q4 24 | $210.6M | $1.2B | ||
| Q3 24 | $227.6M | $985.3M | ||
| Q2 24 | $238.0M | $987.4M | ||
| Q1 24 | — | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PRTSZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $-6.4M | $-32.0M | ||
| Q2 25 | $-25.6M | $-31.0M | ||
| Q1 25 | $5.5M | $-61.7M | ||
| Q4 24 | $1.8M | $-55.8M | ||
| Q3 24 | $8.5M | $-26.8M | ||
| Q2 24 | $-3.6M | $-42.2M | ||
| Q1 24 | — | $-90.1M |
自由现金流PRTSZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $-8.3M | $-35.0M | ||
| Q2 25 | $-27.9M | $-33.9M | ||
| Q1 25 | $3.4M | $-63.2M | ||
| Q4 24 | $-631.0K | $-58.4M | ||
| Q3 24 | $4.9M | $-28.2M | ||
| Q2 24 | $-10.8M | $-42.9M | ||
| Q1 24 | — | $-91.1M |
自由现金流率PRTSZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | -6.5% | -30.4% | ||
| Q2 25 | -18.3% | -31.1% | ||
| Q1 25 | 2.3% | -59.9% | ||
| Q4 24 | -0.5% | -53.8% | ||
| Q3 24 | 3.4% | -27.7% | ||
| Q2 24 | -7.5% | -42.9% | ||
| Q1 24 | — | -104.5% |
资本支出强度PRTSZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 1.5% | 2.6% | ||
| Q2 25 | 1.5% | 2.6% | ||
| Q1 25 | 1.4% | 1.5% | ||
| Q4 24 | 1.8% | 2.4% | ||
| Q3 24 | 2.5% | 1.3% | ||
| Q2 24 | 4.9% | 0.7% | ||
| Q1 24 | — | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRTS
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
